The stock of PDS Biotechnology Corporation (NASDAQ: PDSB) has increased by 6.62 when compared to last closing price of 2.72.Despite this, the company has seen
In the past week, PDSB stock has gone down by -0.61%, with a monthly decline of -29.30% and a quarterly plunge of -33.40%. The volatility
Company’s 36-month beta value is 1.72.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as
The 36-month beta value for PDSB is at 1.70. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0
© 2024, Fueled by Smart TechOne
